The translation of basic science research into medicines for patients requires enabling technologies.
BNTC develops technologies to translate biology and nanoscience discoveries into biopharmaceuticals, nanomedicines, and biomaterials. Our technologies span different aspects of this translation process, including:
- Drug discovery
- Drug development
- Pharmaceutical manufacturing
- Preclinical biological testing
- Product inspection
- Product regulation
The BNTC also has the expertise to test its nanotechnologies using in vitro and in vivo models to facilitate the drug development process.
Outside of its research activities, the BNTC engages in education, service, and technology transfer.
Bruce Yu, PhD, professor in the Department of Pharmaceutical Sciences and director of the Bio- and Nano-Technology Center, was awarded $600,000 from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) for his work to develop new analytical technologies for use in biopharmaceuticals manufacturing.
Research conducted by BNTC members has resulted in a number of new technologies and patents. Learn more about how the center's work is helping to advance therapies for patients around the world.Learn More